Clinical Trial

IMPACT 360 for Parkinson's Disease

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The IMPACT 360 study will evaluate the effects of a combined intervention of exercise, mindfulness, and nutrition on 8 key indicators of health and the mechanisms that drive these changes. 60 subjects aged 40 to 85 with a current diagnosis Parkinson's disease will be recruited. This study will follow a partial crossover design. All participants will receive the intervention. Participants randomized into the intervention group after their baseline screening will receive the 6-month intervention. Those randomized into the waitlist group will complete another assessment at the end of the 6-month care as usual phase before receiving the intervention.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-26
notable Primary completion moved earlier: 2027-05-31 -> 2026-12-31 2026-06-26
Trial Details
NCT Number NCT07443293
Lead Sponsor University of British Columbia
Conditions Parkinson's Disease (PD), REM Sleep Behavior Disorder
Enrollment 60 participants
Start Date 2024-10-28
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-25